NASDAQ:NVAX

Novavax Stock Predictions

etoro logo Buy NVAX
*Your capital is at risk
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NVAX Prediction Chart

NVAX Predictions History

Latest community submissions for NVAX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 29, 2021 $160.00 -27.58% $220.94 X 72.42% 1
JS JS Pro
Jan 26, 2021 $128.57 +1.11% $127.16 X 98.89% 2
JS JS Pro
Jan 25, 2021 $128.06 -2.59% $131.46 X 97.41% 1
Jan 25, 2021 $131.00 -0.35% $131.46 X 99.65% 5
JS JS Pro
Jan 21, 2021 $123.43 +0.84% $122.40 X 99.16% 3
Jan 21, 2021 Bullish $122.40 X 0
JS JS Pro
Oct 12, 2020 $110.72 +0.45% $110.22 X 99.55% 5
Daniel Yordanov Daniel Yordanov @DanielYordanov.175578
Oct 12, 2020 $174.55 +58.37% $110.22 X 41.63% 0
JS JS Pro
Sep 24, 2020 $99.35 -3.02% $102.44 X 96.98% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 14, 2020 $129.57 +22.47% $105.80 X 77.53% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVAX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NOVAVAX INC
Novavax
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE